Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pfizer
>
Exubera Production
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 1862503"]God tells me he can get me out of this mess, but he's pretty sure you're f**ked. </p><p><br /></p><p><a href="http://www.exubera-risks.com/?cat=10&paged=5" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.exubera-risks.com/?cat=10&paged=5" rel="nofollow">http://www.exubera-risks.com/?cat=10&paged=5</a></p><p><br /></p><p>"The company currently makes Exubera at its Terre Haute, Ind. manufacturing facility, then transports the diabetes medication nearly 300 miles to its Portage, Mich. plant for final packaging.</p><p><br /></p><p>Three months ago this blog reported that investment WR Hamcrecht + Co. — which “maintains a market” (i.e., owns) in shares of the co-developer of the inhaled insulin, Nektar Therapeutics (NASDAQ:NKTR) — may have inadvertently disclosed an production risk:</p><p><br /></p><p>Nektar makes all the dry powder insulin (the doses that are inhaled) at its headquarters in San Carlos[, Calif.], and Pfizer has been getting all that it has ordered there.</p><p><br /></p><p>Could having all the Exubera powder made at one facility create a supply-chain risk for Exubera production and sale to diabetic consumers? On a purely practical level, this seems like a rather risky move. "[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 1862503"]God tells me he can get me out of this mess, but he's pretty sure you're f**ked. [url]http://www.exubera-risks.com/?cat=10&paged=5[/url] "The company currently makes Exubera at its Terre Haute, Ind. manufacturing facility, then transports the diabetes medication nearly 300 miles to its Portage, Mich. plant for final packaging. Three months ago this blog reported that investment WR Hamcrecht + Co. — which “maintains a market” (i.e., owns) in shares of the co-developer of the inhaled insulin, Nektar Therapeutics (NASDAQ:NKTR) — may have inadvertently disclosed an production risk: Nektar makes all the dry powder insulin (the doses that are inhaled) at its headquarters in San Carlos[, Calif.], and Pfizer has been getting all that it has ordered there. Could having all the Exubera powder made at one facility create a supply-chain risk for Exubera production and sale to diabetic consumers? On a purely practical level, this seems like a rather risky move. "[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pfizer
>
Exubera Production
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pfizer
>
Exubera Production
>